	2017 Mar 31	2018 Mar 31	R 2019 Mar 31	2020 Mar 31	2021 Mar 31	2022 Mar 31	2023 Mar 31	2024 Mar 31	2025 Mar 31	2026 Mar 31
	2017 Mar 31	2018 Mar 31	R 2019 Mar 31	2020 Mar 31	2021 Mar 31	2022 Mar 31	2023 Mar 31	2024 Mar 31	2025 Mar 31	2026 Mar 31
Period length: Source:	12M PR	12M PR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR
Total Revenue	89.79	97.06	106.28	93.98	70.70	94.08	119.67	221.37	86.72	116.27
Cost of Operating Revenue	73.75	82.45	92.42	85.83	59.77	81.40	106.69	208.52	74.16	94.59
Gross Profit	16.04	14.61	13.86	8.15	10.92	12.68	12.98	12.85	12.55	21.68
Gross Margin	17.9	15.0	13.0	8.7	15.4	13.5	10.8	5.8	14.5	18.6
Total Operating Expenses	86.03	93.04	102.10	90.94	67.41	91.44	116.53	228.97	89.09	113.52
Operating Profit	3.76	4.02	4.18	3.04	3.29	2.64	3.14	-7.60	-2.38	2.75
Operating Margin	4.2	4.1	3.9	3.2	4.6	2.8	2.6	-3.4	-2.7	2.4
Financing Income/(Expense) - Net	-3.34	-3.16	-3.74	-3.06	-3.48	-3.08	-2.19	-1.39	-1.95	-2.00
Profit before Taxes	0.91	1.53	0.89	0.42	0.28	1.10	1.16	2.26	1.17	4.10
Income Taxes	0.25	0.50	0.20	0.11	0.09	0.30	0.26	0.73	0.31	1.06
Profit after Tax	0.66	1.03	0.69	0.31	0.19	0.80	0.91	1.53	0.86	3.05
PAT Margin	0.7	1.1	0.6	0.3	0.3	0.8	0.8	0.7	1.0	2.6
EPS - Basic - ex Extraordinary Items	0.88	1.37	0.91	0.55	0.25	1.06	1.20	2.03	1.14	4.04
EPS - Diluted - ex Extraordinary Items	0.88	1.37	0.91	0.55	0.25	1.06	1.20	2.03	1.14	4.04
EBIT	3.76	4.02	4.18	3.04	3.29	2.64	3.14	-7.60	-2.38	2.75
EBITDA	3.90	4.08	4.23	3.07	3.32	2.68	3.25	-7.11	-1.42	3.85
EBITDA Margin	4.3	4.2	4.0	3.3	4.7	2.8	2.7	-3.2	-1.6	3.3

Balance Sheet

Abridged

Understanding Balance Sheet

Chandra Bhagat Pharma Ltd. balance sheet covering assets, liabilities, equity and borrowings across annual and quarterly periods.

Consolidated

Standalone

Annual

Interim

	2017 Mar 31	2018 Mar 31	C 2019 Mar 31	2020 Mar 31	2021 Mar 31	2022 Mar 31	C 2023 Mar 31	2024 Mar 31	2025 Mar 31	2026 Mar 31
	2017 Mar 31	2018 Mar 31	C 2019 Mar 31	2020 Mar 31	2021 Mar 31	2022 Mar 31	C 2023 Mar 31	2024 Mar 31	2025 Mar 31	2026 Mar 31
Source:	PR	PR	AR	AR	AR	AR	AR	AR	AR	AR
Total Current Assets	55.27	57.05	81.29	72.87	70.01	70.73	58.09	97.92	97.45	87.67
Property Plant & Equipment - Net	0.55	0.51	0.46	0.44	0.42	0.47	0.73	2.52	2.62	2.62
Total Non-Current Assets	0.62	1.00	1.57	1.87	1.77	1.74	2.49	3.89	4.08	6.54
Total Assets	55.90	58.06	82.86	74.74	71.78	72.46	60.58	101.80	101.53	94.21
Total Current Liabilities	37.18	28.63	52.50	34.07	32.87	38.05	26.95	71.06	69.25	58.48
Long Term Debt	4.22	11.74	11.46	10.89	9.45	5.42	3.93	1.41	2.28	2.57
Total Non-Current Liabilities	11.31	20.98	15.91	14.98	13.03	7.74	6.16	1.74	2.31	2.60
Total Liabilities	48.49	49.61	68.41	49.05	45.90	45.79	33.10	72.80	71.56	61.08
Total Shareholders' Equity	7.41	8.44	14.45	25.69	25.88	26.68	27.48	29.01	29.97	33.13
Total Equity	7.41	8.44	14.45	25.69	25.88	26.68	27.48	29.01	29.97	33.13
Total Liabilities & Equity	55.90	58.06	82.86	74.74	71.78	72.46	60.58	101.80	101.53	94.21

Cash Flow

Abridged

Understanding Cash Flow Statement

Chandra Bhagat Pharma Ltd. cash flow statement covering operating, investing and financing activities across annual and quarterly periods.

Consolidated

Standalone

Annual

Interim

	2017 Mar 31	2018 Mar 31	C 2019 Mar 31	2020 Mar 31	2021 Mar 31	2022 Mar 31	2023 Mar 31	2024 Mar 31	2025 Mar 31	2026 Mar 31
	2017 Mar 31	2018 Mar 31	C 2019 Mar 31	2020 Mar 31	2021 Mar 31	2022 Mar 31	2023 Mar 31	2024 Mar 31	2025 Mar 31	2026 Mar 31
Period length: Source:	12M PR	12M PR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR
Operating CF bef Changes in Working Cap	1.06	1.59	0.94	0.45	0.22	1.03	0.94	2.29	1.49	4.73
Working Capital - Increase/(Decrease)	-13.11	-10.84	-0.65	-10.53	4.04	8.45	2.14	2.50	-9.00	2.54
Net CF from Operating Activities	-12.06	-9.25	0.29	-10.08	4.26	9.47	3.08	4.80	-7.51	7.27
Capital Expenditures - Net	0.00	0.02	0.01	0.00	0.02	0.09	0.37	2.28	1.20	0.92
Net CF from Investing Activities	0.00	-0.45	-0.63	-0.35	0.07	0.00	-0.06	-1.86	-1.25	-0.47
Stock - Issuance/(Retirement) - Net	-	-	0.25	2.18	-	-	-	-	-	-
Debt - LT & ST - Issuance/(Retirement) - Total	11.31	9.67	-5.04	-0.93	-1.96	-6.55	-2.26	-4.41	4.14	-4.35
Net Cash Flow from Financing Activities	11.31	9.67	0.26	10.00	-1.96	-6.55	-2.26	-4.41	4.14	-4.35
Free Cash Flow to Equity	-0.75	0.41	-4.76	-11.01	2.28	2.84	0.45	-1.90	-4.58	2.00
Free Operating CF net dividend	-12.06	-9.26	0.28	-10.08	4.24	9.37	2.71	2.51	-8.72	6.35
Free Operating CF	-12.06	-9.26	0.28	-10.08	4.24	9.37	2.71	2.51	-8.72	6.35

Business Segment Analysis

Chandra Bhagat Pharma Ltd. business segment breakdown covering revenue, operating income and assets across key divisions for the selected financial year.

We don't have enough data to show business segment analysis for Chandra Bhagat Pharma Ltd.

Regional Segment Analysis

Chandra Bhagat Pharma Ltd. geographic revenue split showing domestic and international market performance across revenue and income for the selected financial year.

We don't have enough data to show regional segment analysis for Chandra Bhagat Pharma Ltd.

Historical Segment Analysis

Track how Chandra Bhagat Pharma Ltd. segment contributions have evolved over multiple financial years to see which divisions are growing, shrinking or gaining strategic importance.

We don't have enough data to show segments for Chandra Bhagat Pharma Ltd.

Frequently Asked Questions

What is the revenue of Chandra Bhagat Pharma Ltd.?

The latest trailing twelve month revenue of Chandra Bhagat Pharma Ltd. is ₹ 116.27 Cr, reflecting a 1-year growth of 34.08% and a 3-year CAGR of -0.96%. Annual and quarterly revenue trends are available in the Income Statement section.

What is the net profit of Chandra Bhagat Pharma Ltd.?

The latest trailing twelve month net profit (PAT) of Chandra Bhagat Pharma Ltd. is ₹ 3.05 Cr, with a 3-year earnings CAGR of 49.88%. Detailed profit history across annual and quarterly periods is in the Income Statement section.

What is the EBITDA of Chandra Bhagat Pharma Ltd.?

The trailing twelve month EBITDA of Chandra Bhagat Pharma Ltd. is approximately ₹ 2.75 Cr (based on an operating margin of 2.37%). EBITDA reflects core operating profitability before interest, taxes, depreciation and amortisation.

What is the EPS of Chandra Bhagat Pharma Ltd.?

The trailing twelve month Earnings Per Share (EPS) of Chandra Bhagat Pharma Ltd. is 4.04. EPS trends across annual and quarterly periods are visible in the Income Statement section.

What is the debt level of Chandra Bhagat Pharma Ltd.?

The debt-to-equity ratio of Chandra Bhagat Pharma Ltd. stands at 0.50. The interest coverage ratio is 1.38x, reflecting the company's ability to service debt from operating earnings. The full breakdown of total borrowings is in the Balance Sheet section.

What is the book value per share of Chandra Bhagat Pharma Ltd.?

The estimated book value per share of Chandra Bhagat Pharma Ltd. is 43.91 (derived from a P/B ratio of 1.14 and market price of ₹ 49.90), reflecting the net asset value attributable to each share. See the Balance Sheet section for a full breakdown.

What is the cash flow from operations of Chandra Bhagat Pharma Ltd.?

The trailing twelve month operating cash flow of Chandra Bhagat Pharma Ltd. is ₹ 7.27 Cr. Annual and quarterly cash flow data is available in the Cash Flow section of the Statements tab.

Does Chandra Bhagat Pharma Ltd. report consolidated or standalone financials?

Chandra Bhagat Pharma Ltd. reports consolidated financials. You can toggle between consolidated and standalone views using the switch at the top of each statement section.